Source: Annual Congress 2006 - Novel research results in genetics and epidemiology of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Mesia-Vela, C. C. Yeh, C. A. Powell, Y. Wang, J. H. M. Austin, R. M. Santella, R. G. Barr (New York, United States Of America). Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers. Eur Respir J 2006; 28: Suppl. 50, 898

Member's Comments

No comment yet.

Related content which might interest you: Elevated serum levels of oxidative stress biomarkers in patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 Serum endostatin is a novel marker for COPD associated to lung function decline and exacerbation Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Total desmosines in plasma and urine correlate with lung function Source: Eur Respir J 2012; 39: 839-845 Year: 2012 The level of MDA in BALF might reflect oxidative tissue damage in patients with mild MAC pulmonary disease. Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020 Leptin levels are associated with reduced lung function in men with COPD Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 Oxidative modification of proteins of blood plasma in patients with interstitial lung diseases Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Overexpression of RAGE in lungs of patients with COPD: A contributor to oxidative stress in COPD Source: Annual Congress 2011 - Recent developments in COPD Year: 2011 Comparison of oxidative stress markers in 3 matrices (EBC, blood and urine) in patients with occupational lung fibrosis and control subjects Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease Year: 2010 Senescence marker protein-30 decreases oxidative stress in human lungs of smokers with chronic obstructive pulmonary disease Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008 Effect of one moderate or mild exacerbation on lung function and serum inflammatory markers in ex smokers patients with COPD Source: Annual Congress 2009 - Cellular-tissue modifications and functional evaluation in COPD patients Year: 2009 Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Plasma level of total hydroperoxide (TH) as a marker of oxidative stress seems to be a useful index of disease severity in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Beclin1 circulating levels and accelerated ageing markers in COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 The interrelation between inflammation markers and protease-antiprotease status in blood serum in patients with stable COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 COPD patients exhibit abnormally increased peripheral neutrophil stiffening not different from smokers with normal lung function Source: Annual Congress 2009 - Functional insights into COPD Year: 2009 Increased oxidative stress and altered antioxidant status in Chinese patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 62s Year: 2004 Low doses of PM2.5 induces inflammation and oxidative stress with lung functional changes in mice Source: Annual Congress 2008 - Lung, traffic and volcanoes Year: 2008 Oxidative stress and airway inflammation in healthy smokers and COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020